- Home
- ESPR vs CRNT Comparison
ESPR vs CRNT Comparison
Compare ESPR & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- CRNT
- Stock Information
- Founded
- ESPR 2008
- CRNT 1996
- Country
- ESPR United States
- CRNT Israel
- Employees
- ESPR N/A
- CRNT N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- CRNT Radio And Television Broadcasting And Communications Equipment
- Sector
- ESPR Health Care
- CRNT Technology
- Exchange
- ESPR Nasdaq
- CRNT Nasdaq
- Market Cap
- ESPR 305.0M
- CRNT 303.2M
- IPO Year
- ESPR 2013
- CRNT 2000
- Fundamental
- Price
- ESPR $1.69
- CRNT $2.53
- Analyst Decision
- ESPR Buy
- CRNT Strong Buy
- Analyst Count
- ESPR 7
- CRNT 5
- Target Price
- ESPR $6.36
- CRNT $6.15
- AVG Volume (30 Days)
- ESPR 4.2M
- CRNT 1.6M
- Earning Date
- ESPR 03-04-2025
- CRNT 05-06-2025
- Dividend Yield
- ESPR N/A
- CRNT N/A
- EPS Growth
- ESPR N/A
- CRNT 285.71
- EPS
- ESPR N/A
- CRNT 0.27
- Revenue
- ESPR $332,314,000.00
- CRNT $394,190,000.00
- Revenue This Year
- ESPR $5.51
- CRNT $3.36
- Revenue Next Year
- ESPR $1.42
- CRNT $7.39
- P/E Ratio
- ESPR N/A
- CRNT $9.56
- Revenue Growth
- ESPR 185.66
- CRNT 13.54
- 52 Week Low
- ESPR $1.47
- CRNT $2.33
- 52 Week High
- ESPR $3.94
- CRNT $5.73
- Technical
- Relative Strength Index (RSI)
- ESPR 49.78
- CRNT 33.48
- Support Level
- ESPR $1.47
- CRNT $2.36
- Resistance Level
- ESPR $1.61
- CRNT $2.81
- Average True Range (ATR)
- ESPR 0.12
- CRNT 0.13
- MACD
- ESPR 0.02
- CRNT 0.06
- Stochastic Oscillator
- ESPR 56.41
- CRNT 37.78
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and global distribution of its business, providing high-capacity wireless connectivity solutions to global markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the major revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.